Ari Frenkel, MD MPH Expert Witness
Curriculum Vitae

Infectious Disease Expert Witness (FL TX AL)

Contact this Expert Witness

  • Phone: 917-623-2969
  • Cell: 917-623-2969

Specialties & Experience of this Expert Witness

General Specialties:

Infectious Diseases and Internal Medicine

Keywords/Search Terms:

Sepsis, delayed antibiotics, delayed diagnosis, Epidural abscess, Endocarditis, Bacteremia, MRSA, C. DIFF, Osteomyelitis, Septic Arthritis, Healthcare associated infection, CLABSI, Meningitis, Failure to diagnose, Necrotizing, Septic shock, Prosthetic device infection, Failure to act on test result, Failure to follow up, Surgical

Education:

Doctor of Medicine , Saint Matthew's University ; Internal Medicine, United Health Service Hospitals; Infectious Disease, East Carolina University ; Master of Public Health , Yale University School of Public Health

Years in Practice:

17

Additional Information

Board-certified Infectious Disease expert witness with over 17 years of combined clinical and leadership experience with a focus on infectious disease management and standard of care. Expertise includes failure to diagnose infection, sepsis management, delayed antibiotic therapy, and hospital-acquired infections. Readily available to be retained for case review, deposition, and trial testimony as an infectious disease expert witness in cases involving sepsis, failure to diagnose, delayed treatment, and infection-related complications. I evaluate deviation from the standard of care and causation in complex infectious disease cases. Case focus includes: - Failure or delay in diagnosis of infection and sepsis - Delayed or inappropriate antibiotic therapy (standard of care) - Hospital-acquired infections: CLABSI, MRSA, C. difficile - Failure to obtain an infectious disease consult - Bacteremia, endocarditis, osteomyelitis - Epidural abscess and meningitis mismanagement - Device/prosthetic and surgical site infections - Failure to act on critical lab results or follow-up - Infection-related amputations and complications Former Director of Antimicrobial Stewardship and Medical Director of Infectious Disease across multi-hospital systems, with extensive experience in infection management, antibiotic utilization, and clinical protocols. Experienced in evaluating care in hospital, acute, and post-acute settings. Currently Co-Founder and Chief Science Officer of a biotechnology company focused on AI-driven antimicrobial stewardship and clinical decision support. Regularly advise clinicians on infectious disease standard of care and complex case management. Academic faculty member, published author, and co-author of Molecular Diagnostics of Infectious Diseases (2025), with expertise in diagnostic microbiology and application of laboratory data to time-sensitive treatment decisions.